Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 CAD | 0.00% | -6.67% | -36.36% |
Valuation
Fiscal Period: August | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 22.48 | 172.5 | 92.25 | 51.96 | 22.44 | - | - |
Enterprise Value (EV) 1 | 22.48 | 172.5 | 92.25 | 51.96 | 22.44 | 22.44 | 22.44 |
P/E ratio | -1.57 x | - | - | -1.77 x | -1.17 x | -7 x | 7 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 25.5 x | 114 x | 14.2 x | 2.24 x | 1.02 x | 0.67 x | 0.49 x |
EV / Revenue | 25.5 x | 114 x | 14.2 x | 2.24 x | 1.02 x | 0.67 x | 0.49 x |
EV / EBITDA | - | -11,206,812 x | -3,358,265 x | - | - | - | - |
EV / FCF | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 95,651 | 202,988 | 256,237 | 266,455 | 320,552 | - | - |
Reference price 2 | 0.2350 | 0.8500 | 0.3600 | 0.1950 | 0.0700 | 0.0700 | 0.0700 |
Announcement Date | 29/12/20 | 09/12/21 | 29/11/22 | 29/11/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: August | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 0.8812 | 1.514 | 6.494 | 23.18 | 21.91 | 33.35 | 46.06 |
EBITDA | - | -15.4 | -27.47 | - | - | - | - |
EBIT 1 | - | - | -28.45 | -29.52 | -15.32 | -3.372 | 4.032 |
Operating Margin | - | - | -438.1% | -127.36% | -69.94% | -10.11% | 8.75% |
Earnings before Tax (EBT) 1 | - | - | - | -30.26 | -16.47 | -3.372 | 4.032 |
Net income 1 | - | - | - | -30.26 | -16.47 | -3.372 | 4.032 |
Net margin | - | - | - | -130.53% | -75.2% | -10.11% | 8.75% |
EPS 2 | -0.1500 | - | - | -0.1100 | -0.0600 | -0.0100 | 0.0100 |
Free Cash Flow | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 29/12/20 | 09/12/21 | 29/11/22 | 29/11/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: August | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 0.7896 | 0.7861 | 0.7411 | 4.177 | 5.668 | 5.355 | 6.027 | 6.131 | 5.946 | 5.031 | 5.465 | 5.464 | 6.761 | 8.004 | 8.959 |
EBITDA | - | - | - | -9.01 | -6.288 | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | - | - | - | -9.638 | -6.703 | -7.093 | -6.526 | -8.624 | -4.165 | -5.045 | -3.644 | -2.469 | - | - | - |
Operating Margin | - | - | - | -230.72% | -118.25% | -132.47% | -108.28% | -140.66% | -70.04% | -100.28% | -66.68% | -45.19% | - | - | - |
Earnings before Tax (EBT) 1 | - | - | - | - | - | -7.293 | -7.28 | -9.386 | -4.406 | -5.954 | -3.644 | -2.469 | - | - | - |
Net income 1 | - | - | - | - | - | -7.331 | -7.289 | -9.338 | -4.406 | -5.954 | -3.644 | -2.469 | - | - | - |
Net margin | - | - | - | - | - | -136.92% | -120.94% | -152.32% | -74.11% | -118.35% | -66.68% | -45.19% | - | - | - |
EPS 2 | - | - | - | - | - | -0.0300 | -0.0300 | -0.0300 | -0.0200 | -0.0200 | -0.0100 | -0.0100 | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 20/01/22 | 14/04/22 | 14/07/22 | 29/11/22 | 16/01/23 | 13/04/23 | 17/07/23 | 29/11/23 | 15/01/24 | 13/04/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: August | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | 1.25 | - | - | - | - |
Capex / Sales | - | - | 19.19% | - | - | - | - |
Announcement Date | 29/12/20 | 09/12/21 | 29/11/22 | 29/11/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.36% | 16.4M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- NUMI Stock
- Financials Numinus Wellness Inc.